LATEST NEWS
EXACT Therapeutics initiates preclinical immunotherapy collaboration with Agenus Inc.
EXACT Therapeutics announces grant of immunotherapy patent
EXACT Therapeutics has been informed that the Intellectual Property Office in United Kingdom will today grant EXACT its United Kingdom Patent entitled “Enhancement of Treatment with Immunotherapeutic Agents”.
EXACT Therapeutics to Present at the Annual International Symposium on Therapeutic Ultrasound (ISTU 2024)
EXACT Therapeutics Company update: Full focus on Phase 2 pancreatic cancer trial
Wall Street Journal:
New Ultrasound Therapy Could Help Treat Alzheimer’s, Cancer